{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:57:05Z","timestamp":1773017825356,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Disseminated\n                      <jats:italic>Mycobacterium avium<\/jats:italic>\n                      complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced human immunodeficiency virus (HIV) infection. Effective antiretroviral therapy has dramatically reduced the incidence of and mortality due to HIV infection, although drug resistance and poor medication adherence continue to increase the risk of disseminated\n                      <jats:italic>M. avium<\/jats:italic>\n                      complex infection. However, gastrointestinal lesions in cases of disseminated\n                      <jats:italic>M. avium<\/jats:italic>\n                      complex infection resulting in protein-losing enteropathy have been rarely discussed. Therefore, we present a case of protein-losing enteropathy caused by disseminated\n                      <jats:italic>M. avium<\/jats:italic>\n                      complex infection in a patient undergoing antiretroviral therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 29-year-old man was diagnosed with AIDS 4 years ago and was admitted for a 10-month history of refractory diarrhea and fever. Despite receiving antiretroviral therapy, the viral load remained elevated due to poor medication adherence. The patient was diagnosed with disseminated\n                      <jats:italic>M. avium<\/jats:italic>\n                      complex infection and started on antimycobacterial drugs 2 years before admission. However, the infection remained uncontrolled. The previous hospitalization 1 year before admission was due to hypoalbuminemia and refractory diarrhea. Upper gastrointestinal endoscopy revealed a diagnosis of protein-losing enteropathy caused by intestinal lymphangiectasia, and treatment with intravenous antimycobacterial drugs did not resolve his intestinal lymphangiectasia. The patient inevitably died of sepsis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Clinical remission is difficult to achieve in patients with AIDS and protein-losing enteropathy caused by disseminated\n                      <jats:italic>M. avium<\/jats:italic>\n                      complex infection due to limited options of parenteral antiretroviral drugs. This report highlights the importance of identifying alternative treatments (such as an injectable formulation) for patients who do not respond to antiretroviral therapy due to protein-losing enteropathy with disseminated\n                      <jats:italic>M. avium<\/jats:italic>\n                      complex infection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-021-00417-0","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T07:02:49Z","timestamp":1638169369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-6487","authenticated-orcid":false,"given":"Keiji","family":"Konishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Nakahira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"Shirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1148\/radiology.219.1.r01ap2986","volume":"219","author":"NT Chiu","year":"2001","unstructured":"Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology. 2001;219:86\u201390. https:\/\/doi.org\/10.1148\/radiology.219.1.r01ap2986.","journal-title":"Radiology"},{"key":"417_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-3-5","volume":"3","author":"S Vignes","year":"2008","unstructured":"Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann\u2019s disease). Orphanet J Rare Dis. 2008;3:5. https:\/\/doi.org\/10.1186\/1750-1172-3-5.","journal-title":"Orphanet J Rare Dis"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10156-009-0698-4","volume":"15","author":"E Ogawa","year":"2009","unstructured":"Ogawa E, Murata M, Unno M, Otaguro S, Kainuma M, Sawayama Y, et al. Protein-losing enteropathy during highly active antiretroviral therapy in a patient with AIDS-related disseminated mycobacterial avium complex infection. J Infect Chemother. 2009;15:252\u20136. https:\/\/doi.org\/10.1007\/s10156-009-0698-4.","journal-title":"J Infect Chemother"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.amjms.2020.09.007","volume":"361","author":"R Bansal","year":"2021","unstructured":"Bansal R, Ayoub M, Policar M. Gastrointestinal Mycobacterium avium complex. Am J Med Sci. 2021;361:e31\u20132. https:\/\/doi.org\/10.1016\/j.amjms.2020.09.007.","journal-title":"Am J Med Sci"},{"key":"417_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJM199105093241906","volume":"324","author":"CR Horsburgh Jr","year":"1991","unstructured":"Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:1332\u20138. https:\/\/doi.org\/10.1056\/NEJM199105093241906.","journal-title":"N Engl J Med"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella Jr","year":"1998","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338:853\u201360. https:\/\/doi.org\/10.1056\/NEJM199803263381301.","journal-title":"N Engl J Med"},{"key":"417_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3748\/wjg.15.1050","volume":"15","author":"AL Werneck-Silva","year":"2009","unstructured":"Werneck-Silva AL, Prado IB. Role of upper endoscopy in diagnosing opportunistic infections in human immunodeficiency virus-infected patients. World J Gastroenterol. 2009;15:1050\u20136. https:\/\/doi.org\/10.3748\/wjg.15.1050.","journal-title":"World J Gastroenterol"},{"key":"417_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s0016-5107(04)02786-5","volume":"61","author":"HY Sun","year":"2005","unstructured":"Sun HY, Chen MY, Wu MS, Hsieh SM, Fang CT, Hung CC, et al. Endoscopic appearance of GI mycobacteriosis caused by the mycobacterium avium complex in a patient with AIDS: case report and review. Gastrointest Endosc. 2005;61:775\u20139. https:\/\/doi.org\/10.1016\/s0016-5107(04)02786-5.","journal-title":"Gastrointest Endosc"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4275::AID-IMMU4275>3.0.CO;2-P","volume":"28","author":"IJ Fuss","year":"1998","unstructured":"Fuss IJ, Strober W, Cuccherini BA, Pearlstein GR, Bossuyt X, Brown M, et al. Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol. 1998;28:4275\u201385.","journal-title":"Eur J Immunol"},{"key":"417_CR10","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.2169\/internalmedicine.55.6777","volume":"55","author":"M Ikuma","year":"2016","unstructured":"Ikuma M, Watanabe D, Yagura H, Ashida M, Takahashi M, Shibata M, et al. Therapeutic drug monitoring of anti-human immunodeficiency virus drugs in a patient with short bowel syndrome. Intern Med. 2016;55:3059\u201363. https:\/\/doi.org\/10.2169\/internalmedicine.55.6777.","journal-title":"Intern Med"},{"key":"417_CR11","unstructured":"Guidelines for the use of antiretroviral agents in HIV-1\u2014infected adults and adolescents. Department of Health and Human Services.\u00a0https:\/\/aidsinfo.nih.gov\/. Accessed 15 Jul 2021."},{"key":"417_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMoa1904398","volume":"382","author":"S Swindells","year":"2020","unstructured":"Swindells S, Andrade-Villanueva JF, Richmond GJ, Rizzardini G, Baumgarten A, Masi\u00e1 M, et al. Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression. N Engl J Med. 2020;382:1112\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1904398","journal-title":"N Engl J Med"},{"key":"417_CR13","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/S0140-6736(20)32666-0","volume":"396","author":"ET Overton","year":"2021","unstructured":"Overton ET, Richmond G, Rizzardini G, Jaeger H, Orrell C, Nagimova F, et al. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2\u00a0M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. Lancet. 2021;396:1994\u20132005. https:\/\/doi.org\/10.1016\/S0140-6736(20)32666-0","journal-title":"Lancet"},{"key":"417_CR14","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/S2352-3018(20)30340-4","volume":"8","author":"C Orkin","year":"2021","unstructured":"Orkin C, Oka S, Philibert P, Brinson C, Bassa A, Gusev D, et al. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. Lancet HIV. 2021;8:e185\u201396. https:\/\/doi.org\/10.1016\/S2352-3018(20)30340-4","journal-title":"Lancet HIV"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00417-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-021-00417-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00417-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T07:13:20Z","timestamp":1638170000000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-021-00417-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1186\/s12981-021-00417-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-754298\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent and protocols were obtained and approved by the Human Ethics Committee of Osaka City General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}